Secondary acute myeloid leukaemia has a worse outcome than de novo AML, even taking into account cytogenetics and age.  AML10,11,12 MRC Trials

AH Goldstone; AK Burnett; I Avivi; Robert Hills; Keith Wheatley

Secondary acute myeloid leukaemia has a worse outcome than de novo AML, even taking into account cytogenetics and age. AML10,11,12 MRC Trials

AH Goldstone, AK Burnett, I Avivi, Robert Hills, Keith Wheatley

Research output: Contribution to conference (unpublished) › Paper

Original language	English
Pages	88a Abs322
Publication status	Published - 1 Jan 2002

Cite this

@conference{1d4fc1bd073e4aff9277d527d25c7d52,

title = "Secondary acute myeloid leukaemia has a worse outcome than de novo AML, even taking into account cytogenetics and age. AML10,11,12 MRC Trials",

author = "AH Goldstone and AK Burnett and I Avivi and Robert Hills and Keith Wheatley",

year = "2002",

month = jan,

day = "1",

language = "English",

pages = "88a Abs322",

}